NCI Symposium on Mutation Signatures and Cancer: Analytical Approaches

During the 3rd session of the NCI Symposium on Mutation Signatures and Cancer, Dr. Teresa Przytycka (NCBI), Dr. David Wedge (University of Manchester), Dr. Peter Park (Harvard University), and Dr. Joshua Campbell (Boston University) share analytical approaches to study mutation signatures.